To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SP140LandSP100andHMGB1L3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
654 supporting clones for gene SP140LandSP100andHMGB1L3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP239074 Liver .a 1 to 600 1 to 601   tiling clone,   601/601
(100 %)
18 diff
(97.1 %id)
AF255565   .a 325 to 3151 1 to 2827 M826T tiling clone,   2827/2827
(100 %)
2 diff
(100.0 %id)
CN363113 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 331 to 980 1 to 650       650/650
(100 %)
0 diff
(100 %id)
BU507268 leiomyosarcoma, uterus .a 331 to 1032 1 to 710       710/811
(87 %)
19 diff
(97.7 %id)
CV028622 mixed .a 356 to 978 1 to 619       619/622
(99 %)
5 diff
(99.2 %id)
TI_1948132142   .a 356 to 1091 126 to 862       737/1417
(52 %)
13 diff
(99.1 %id)
TI_1948132769   .a 356 to 1087 133 to 862       730/1342
(54 %)
18 diff
(98.7 %id)
BI821313 pooled brain, lung, testis .a 386 to 961 70 to 634       565/634
(89 %)
21 diff
(96.7 %id)
TI_57200462   .a 386 to 961 95 to 659       565/659
(85 %)
21 diff
(96.9 %id)
DB243852 stomach, tumor tissue .a 404 to 969 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA046691 bladder .a 405 to 972 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BF237471 leiomyosarcoma cell line, uterus .a 414 to 1139 1 to 729       729/729
(100 %)
16 diff
(97.9 %id)
NM_003113.3   .b 1 to 3666 1 to 3666 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3666/3666
(100 %)
0 diff
(100 %id)
DA562355 heart .b 2 to 586 2 to 586   tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
DB002900 breast, tumor tissue .b 14 to 556 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
BP274535 Kidney .b 26 to 605 1 to 581       581/582
(99 %)
4 diff
(99.4 %id)
BP291661 lung .b 26 to 597 1 to 573       573/573
(100 %)
13 diff
(97.8 %id)
DA261297 caudate nucleus .b 27 to 594 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA682070 ovary .b 27 to 584 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA678000   .b 39 to 619 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
AU135411 placenta .b 39 to 795 2 to 773   capped   770/784
(98 %)
16 diff
(98.0 %id)
DA999848 breast, tumor tissue .b 39 to 605 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BG485502 lung .b 45 to 856 1 to 829       800/940
(85 %)
30 diff
(96.9 %id)
DB225106 trachea .b 45 to 631 2 to 587   capped   586/591
(99 %)
2 diff
(99.7 %id)
BP252192 Kidney .b 46 to 626 1 to 581       581/581
(100 %)
0 diff
(100 %id)
CF593779 Human Placenta, placenta .b 46 to 807 29 to 793       765/794
(96 %)
18 diff
(97.8 %id)
DA045694 bladder .b 47 to 613 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA249375 brain .b 47 to 644 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DA566742 heart .b 47 to 593 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA821170 pericardium .b 48 to 618 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA377512 thalamus .b 51 to 633 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
BQ229896 epithelioid carcinoma, Pancreas .b 54 to 837 1 to 787       787/789
(99 %)
7 diff
(99.2 %id)
CD616294   .b 56 to 547 25 to 522       498/522
(95 %)
17 diff
(96.8 %id)
DA966602 stomach .b 56 to 621 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BI860770 breast, mammary adenocarcinoma, cell line .b 57 to 890 1 to 830       826/830
(99 %)
26 diff
(96.9 %id)
TI_57192754   .b 57 to 890 54 to 883       826/830
(99 %)
26 diff
(96.9 %id)
AV724371 hypothalamus .b 58 to 675 1 to 615       615/642
(95 %)
16 diff
(97.6 %id)
BM923198 leukocyte .b 58 to 668 72 to 692       621/1378
(45 %)
36 diff
(97.4 %id)
CN482955 eye .b 60 to 684 1 to 625       625/625
(100 %)
0 diff
(100 %id)
DB106964 thymus .b 60 to 636 2 to 578   capped   577/577
(100 %)
4 diff
(99.4 %id)
CB150920 cervix, Uterine .b 61 to 483 1 to 423       423/423
(100 %)
9 diff
(97.9 %id)
BM542327 melanotic melanoma, skin .b 61 to 874 1 to 818       818/979
(83 %)
19 diff
(98.1 %id)
BQ436061 embryonal carcinoma, cell line, testis .b 61 to 824 1 to 771       771/934
(82 %)
23 diff
(97.6 %id)
DA482848   .b 62 to 651 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
BG323885 Kidney, renal cell adenocarcinoma .b 62 to 762 1 to 712       713/1096
(65 %)
26 diff
(97.7 %id)
AU136994 placenta .b 62 to 808 2 to 762   capped   761/815
(93 %)
20 diff
(97.6 %id)
DA015436 adrenal gland .b 64 to 619 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA041141 bladder .b 64 to 536 2 to 474   capped   473/473
(100 %)
1 diff
(99.8 %id)
CN363110 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 64 to 764 9 to 709       701/709
(98 %)
6 diff
(99.2 %id)
DB012055 esophageal, tumor tissue .b 64 to 634 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BP379789 uterus .b 64 to 644 1 to 581       581/581
(100 %)
8 diff
(98.7 %id)
BP207080 coronary artery .b 65 to 639 1 to 575       575/575
(100 %)
6 diff
(99.0 %id)
BP220146 colon .b 65 to 641 1 to 577       577/577
(100 %)
11 diff
(98.1 %id)
BP220622 colon .b 65 to 622 1 to 558       558/558
(100 %)
8 diff
(98.6 %id)
BP222269   .b 65 to 645 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP225899   .b 65 to 644 1 to 580       580/580
(100 %)
0 diff
(100 %id)
BP235095 coronary artery .b 65 to 651 1 to 587       587/587
(100 %)
1 diff
(99.9 %id)
BP235140 coronary artery .b 65 to 652 1 to 588       588/588
(100 %)
5 diff
(99.2 %id)
CB113213 Liver .b 65 to 597 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
DA960190 Spleen .b 65 to 616 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BP341929 stomach mucosa .b 65 to 646 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP351831   .b 65 to 647 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DA040580 bladder .b 66 to 629 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA041611 bladder .b 66 to 636 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA321509 hippocampus .b 66 to 520 2 to 456   capped   455/455
(100 %)
0 diff
(100 %id)
DA433124 cord Blood .b 66 to 536 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DA473605   .b 66 to 621 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA653314   .b 66 to 659 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA677441   .b 66 to 640 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA678017   .b 66 to 500 2 to 438   capped   437/437
(100 %)
2 diff
(99.6 %id)
DA685553   .b 66 to 642 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
DA824418 pericardium .b 66 to 622 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA851451 placenta .b 66 to 582 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DA868728 Prostate .b 66 to 617 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA890000   .b 66 to 628 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA916844 small intestine .b 66 to 622 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA936097 Spleen .b 66 to 659 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DA956505 Spleen .b 66 to 646 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA998011   .b 66 to 621 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DB115647 thymus .b 66 to 628 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DB125078 thymus .b 66 to 564 2 to 501   capped   500/500
(100 %)
1 diff
(99.8 %id)
DB211726 trachea .b 66 to 615 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DB229118 trachea .b 66 to 658 2 to 594   capped   593/593
(100 %)
0 diff
(100 %id)
BP289969 lung .b 67 to 580 1 to 516       516/568
(90 %)
5 diff
(99.2 %id)
DA042974 bladder .b 68 to 526 2 to 462   capped   461/461
(100 %)
2 diff
(99.6 %id)
DA677879   .b 68 to 644 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB003837 breast, tumor tissue .b 68 to 618 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB003838 breast, tumor tissue .b 68 to 614 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DB072793 testis .b 68 to 609 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BP225395   .b 71 to 654 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DA964871 stomach .b 72 to 622 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BM904548 leiomyosarcoma, uterus .b 80 to 580 1 to 503       503/1214
(41 %)
7 diff
(99.5 %id)
BM922530 leukocyte .b 82 to 1113 9 to 1043       1035/1088
(95 %)
21 diff
(98.1 %id)
BG419927 Kidney, renal cell adenocarcinoma .b 84 to 627 1 to 544       544/544
(100 %)
8 diff
(98.6 %id)
CA396759 eye, RPE/choroid .b 85 to 564 1 to 480       480/480
(100 %)
1 diff
(99.8 %id)
BM905778 leiomyosarcoma, uterus .b 89 to 961 1 to 883       883/936
(94 %)
16 diff
(98.3 %id)
BX420062 brain, fetal brain .b 96 to 961 1 to 867       867/867
(100 %)
0 diff
(100 %id)
BX445011 brain, fetal brain .b 96 to 961 1 to 868       868/868
(100 %)
4 diff
(99.6 %id)
BI820495 pooled brain, lung, testis .b 100 to 910 1 to 810       810/813
(99 %)
16 diff
(98.1 %id)
TI_57198868   .b 100 to 910 27 to 836       810/839
(96 %)
20 diff
(97.7 %id)
AF056322   .b 111 to 3666 1 to 3557 exact tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3557/3557
(100 %)
3 diff
(100.0 %id)
AA385828 thyroid gland .b 137 to 484 1 to 349       349/355
(98 %)
6 diff
(98.4 %id)
TI_1948132143   .b 142 to 962 136 to 960       825/1175
(70 %)
17 diff
(98.6 %id)
TI_1948132770   .b 142 to 961 133 to 953       821/1149
(71 %)
13 diff
(98.9 %id)
TI_1948133075   .b 142 to 961 121 to 937       817/1383
(59 %)
23 diff
(98.4 %id)
TI_1948133076   .b 142 to 962 133 to 954       822/1140
(72 %)
17 diff
(98.6 %id)
L79988   .b 1570 to 2871 1 to 1302       1302/1302
(100 %)
3 diff
(99.8 %id)
BM998989 lung, Lung Focal Fibrosis .b 2180 to 2860 35 to 717     Submitted on the opposite strand 683/702
(97 %)
4 diff
(99.5 %id)
BF374115 stomach_normal .b 2189 to 2413 37 to 270       234/270
(86 %)
23 diff
(91.5 %id)
BF374131 stomach_normal .b 2189 to 2706 26 to 544       519/550
(94 %)
16 diff
(97.1 %id)
BG230861 nasopharynx, normal epithelium .b 2841 to 3082 1 to 242       242/243
(99 %)
5 diff
(98.0 %id)
AI378675 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b 2921 to 3363 484 to 41   AAA   444/468
(94 %)
0 diff
(100 %id)
AW978040   .b 2958 to 3566 611 to 1     Submitted on the opposite strand 611/614
(99 %)
23 diff
(96.3 %id)
AI886092 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 3035 to 3161 140 to 14   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 127/127
(100 %)
0 diff
(100 %id)
AA806663 germinal center B cell .b 3123 to 3575 457 to 2   tiling clone,   456/457
(99 %)
0 diff
(100 %id)
BF510057   .b 3182 to 3666 502 to 18   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 485/494
(98 %)
0 diff
(100 %id)
BF510058   .b 3182 to 3666 502 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 485/500
(97 %)
0 diff
(100 %id)
AA368532 placenta .b 3385 to 3665 282 to 2       281/282
(99 %)
0 diff
(100 %id)
NM_007237.4   .c 1 to 3250 1 to 3250 exact RefSeq, AAA   3250/3250
(100 %)
0 diff
(100 %id)
U36500   .c 1 to 3250 1 to 3252 P186A L356F A358T E516K D838G ... tiling clone, AAA   3252/3252
(100 %)
8 diff
(99.8 %id)
BC054890 Pooled, 40 cell lines .c 31 to 811 1 to 781   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 781/800
(97 %)
6 diff
(99.3 %id)
BC038091 Lymph, lymphoma .c 41 to 964 12 to 935   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 924/926
(99 %)
4 diff
(99.6 %id)
BQ049232 lymph, lymphoma, cell line .c 43 to 964 1 to 928   available from MGC,   926/1013
(91 %)
16 diff
(98.5 %id)
BG686318 B-cells, primary B-cells from tonsils (cell line) .c 1861 to 2669 1 to 813       813/817
(99 %)
12 diff
(98.6 %id)
H66483 liver and spleen .c 2294 to 2717 1 to 434   tiling clone,   434/437
(99 %)
15 diff
(96.6 %id)
BF663679 B-cells, primary B-cells from tonsils (cell line) .c 2399 to 3157 1 to 759   tiling clone,   759/821
(92 %)
22 diff
(97.4 %id)
H66484 liver and spleen .c 2790 to 3240 454 to 1       454/455
(99 %)
10 diff
(97.9 %id)
AU310697 neuroblastoma .d 1 to 580 1 to 580   tiling clone,   580/580
(100 %)
1 diff
(99.9 %id)
CN363111 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 924 to 1563 1 to 641   tiling clone,   641/641
(100 %)
3 diff
(99.6 %id)
AU310698 neuroblastoma .d 1060 to 1611 552 to 1       552/552
(100 %)
0 diff
(100 %id)
BU431447 lymph .d 1080 to 1624 1 to 545       545/559
(97 %)
7 diff
(98.8 %id)
BM744037 Ascites, stomach .d 1083 to 1670 1 to 588       588/588
(100 %)
0 diff
(100 %id)
BM743583 Ascites, stomach .d 1083 to 1664 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
TI_154153320   .d 1086 to 1673 79 to 665       587/609
(96 %)
7 diff
(98.9 %id)
AW449837   .d 1160 to 1610 468 to 18   AAA   451/451
(100 %)
3 diff
(99.4 %id)
BE894088 melanotic melanoma, skin .d 1214 to 1966 1 to 755   tiling clone,   755/1122
(67 %)
33 diff
(97.1 %id)
FN117282 breast carcinoma .d 1504 to 1602 1 to 99       99/99
(100 %)
0 diff
(100 %id)
CR749288 salivary gland .d 1859 to 4135 1 to 2277   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2277/2277
(100 %)
2 diff
(100.0 %id)
NM_001080391.1   .e 1 to 5645 2 to 5455 exact RefSeq,   5455/5455
(100 %)
0 diff
(100 %id)
AU100054   .e 25 to 514 1 to 300       300/300
(100 %)
7 diff
(97.7 %id)
AA355869   .e 36 to 526 1 to 300   tiling clone,   300/300
(100 %)
1 diff
(99.7 %id)
AU107100   .e 45 to 94 1 to 50       50/50
(100 %)
0 diff
(100 %id)
BQ581815 insulinoma, Pancreas .e 61 to 547 1 to 296   fully sequenced,   296/296
(100 %)
4 diff
(98.7 %id)
DA040198 bladder .e 65 to 507 2 to 253   capped   252/252
(100 %)
0 diff
(100 %id)
DA969050 stomach .e 67 to 672 2 to 587   tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
DB450916 testis .e 99 to 592 1 to 303       303/306
(99 %)
3 diff
(99.1 %id)
BG193352   .e 168 to 683 1 to 325       325/325
(100 %)
7 diff
(97.9 %id)
BQ336102 marrow .e 174 to 592 1 to 230       230/235
(97 %)
11 diff
(95.4 %id)
AA303647 aorta .e 191 to 665 1 to 284       284/284
(100 %)
2 diff
(99.3 %id)
BQ581499 insulinoma, Pancreas .e 217 to 549 142 to 1   tiling clone, fully sequenced,   142/142
(100 %)
0 diff
(100 %id)
BI438509 Pancreas, Purified pancreatic islet .e 439 to 1057 1 to 619       619/619
(100 %)
0 diff
(100 %id)
AI902624 breast .e 443 to 915 1 to 469       471/482
(97 %)
9 diff
(98.2 %id)
AI902668 breast .e 443 to 603 1 to 161       161/161
(100 %)
0 diff
(100 %id)
BE927291 colon .e 459 to 891 13 to 446       434/459
(94 %)
11 diff
(97.7 %id)
AI902713 breast .e 470 to 602 1 to 133       133/134
(99 %)
2 diff
(98.6 %id)
BU178835 melanotic melanoma, skin .e 470 to 1306 1 to 846   tiling clone,   846/850
(99 %)
19 diff
(97.8 %id)
BG433741 Kidney .e 480 to 1180 1 to 701       701/701
(100 %)
11 diff
(98.5 %id)
AW379884 head_neck .e 482 to 863 383 to 1       383/403
(95 %)
5 diff
(98.8 %id)
AW819664 stomach .e 491 to 1085 18 to 612       595/612
(97 %)
11 diff
(98.3 %id)
BF375626 stomach .e 492 to 850 32 to 390       359/390
(92 %)
7 diff
(98.3 %id)
DA474370   .e 506 to 1070 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BE549084 cervical carcinoma cell line, cervix .e 513 to 1054 1 to 552       552/552
(100 %)
13 diff
(97.7 %id)
BG390887 embryonal carcinoma, cell line, testis .e 522 to 1234 1 to 712       712/712
(100 %)
3 diff
(99.6 %id)
CD703349 normal nasopharynx .e 530 to 1032 29 to 531       503/531
(94 %)
8 diff
(98.5 %id)
BP261919 small intestine .e 530 to 1111 1 to 583       583/583
(100 %)
4 diff
(99.4 %id)
BG698644 skin .e 554 to 1339 1 to 790       790/790
(100 %)
7 diff
(99.2 %id)
BI824918 pooled brain, lung, testis .e 555 to 1332 13 to 785       776/785
(98 %)
15 diff
(98.1 %id)
TI_57196025   .e 555 to 1332 13 to 785       776/785
(98 %)
15 diff
(98.1 %id)
BU180147 melanotic melanoma, cell line, skin .e 557 to 1230 1 to 679       679/891
(76 %)
13 diff
(98.6 %id)
BM876369 insulinoma, Pancreas .e 564 to 1160 1 to 597     Submitted on the opposite strand 597/597
(100 %)
1 diff
(99.9 %id)
DA046388 bladder .e 567 to 1131 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BQ931538 epidermoid carcinoma, cell line, lung .e 568 to 1304 1 to 739       737/945
(77 %)
4 diff
(99.6 %id)
BG462093   .e 603 to 1110 511 to 8     Submitted on the opposite strand 504/512
(98 %)
4 diff
(99.3 %id)
BE869308 adenocarcinoma, colon .e 604 to 1218 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BQ336150 marrow .e 605 to 722 1 to 118       118/118
(100 %)
1 diff
(99.2 %id)
AI902667 breast .e 617 to 768 1 to 152       152/152
(100 %)
0 diff
(100 %id)
AI902712 breast .e 617 to 869 1 to 254       254/262
(96 %)
5 diff
(98.1 %id)
BF737651 bladder_tumor .e 638 to 918 1 to 281       281/281
(100 %)
1 diff
(99.7 %id)
BE813783 breast_normal .e 645 to 936 7 to 296       290/296
(97 %)
1 diff
(99.7 %id)
CB149481 Liver .e 648 to 792 1 to 145       145/145
(100 %)
0 diff
(100 %id)
DA761048 tongue .e 654 to 1186 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
BE385118 melanotic melanoma, skin .e 674 to 1290 1 to 614       614/649
(94 %)
4 diff
(99.4 %id)
BE390337 endometrium, adenocarcinoma cell line, uterus .e 675 to 1304 1 to 630       630/644
(97 %)
6 diff
(99.1 %id)
BE388117 endometrium, adenocarcinoma cell line, uterus .e 676 to 1304 1 to 629       629/699
(89 %)
11 diff
(98.5 %id)
BF026909 melanotic melanoma, skin .e 676 to 1472 1 to 805       802/893
(89 %)
26 diff
(97.1 %id)
AW749638 breast .e 697 to 889 208 to 16       193/208
(92 %)
7 diff
(96.7 %id)
AA057712.
matches multiple genes
cornea .e 707 to 1319 1 to 612     also hits gene RARRES2 612/612
(100 %)
8 diff
(98.7 %id)
EC540508 Prostate .e 719 to 812 22 to 115       94/115
(81 %)
6 diff
(94.8 %id)
CD513018 brain, Pituitary .e 745 to 1466 28 to 752       725/953
(76 %)
14 diff
(98.6 %id)
BX093217 senescent fibroblast .e 755 to 1345 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
CB216535 normal endometrium, mid-secretory phase,cycle day 23, uterus .e 760 to 1386 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BF805250 colon_ins .e 813 to 1151 1 to 341       341/341
(100 %)
4 diff
(98.9 %id)
AA120879 uterus .e 823 to 1244 1 to 440     Submitted on the opposite strand 436/442
(98 %)
19 diff
(95.8 %id)
CD686492 normal nasopharynx .e 829 to 1315 39 to 525       487/525
(92 %)
6 diff
(98.9 %id)
BQ434757 leiomyosarcoma, uterus .e 869 to 1751 1 to 885       885/895
(98 %)
17 diff
(98.2 %id)
AA341731 Kidney .e 881 to 1135 1 to 255       255/255
(100 %)
0 diff
(100 %id)
BI020591 marrow .e 891 to 1256 366 to 1       366/366
(100 %)
0 diff
(100 %id)
TI_1948132771   .e 917 to 1766 981 to 117       876/1320
(66 %)
77 diff
(94.2 %id)
TI_1948133077   .e 917 to 1766 981 to 117       878/1277
(68 %)
64 diff
(95.0 %id)
TI_1948132144   .e 924 to 1766 973 to 118       869/1313
(66 %)
71 diff
(94.6 %id)
FN087545 breast carcinoma .e 974 to 1067 1 to 93       93/98
(94 %)
2 diff
(98.0 %id)
BP322657 Pancreas .e 976 to 1560 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BI031376 marrow .e 980 to 1265 11 to 295       285/305
(93 %)
9 diff
(97.1 %id)
T29489 prostate gland .e 983 to 1218 1 to 236       236/236
(100 %)
0 diff
(100 %id)
BP222290   .e 984 to 1567 1 to 583       583/583
(100 %)
7 diff
(98.8 %id)
BP222330   .e 984 to 1564 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BG403534 bladder, transitional cell papilloma, cell line .e 1066 to 1730 1 to 670       670/749
(89 %)
11 diff
(98.6 %id)
CD693780 normal nasopharynx .e 1103 to 1600 20 to 517       498/517
(96 %)
6 diff
(98.9 %id)
FN052756 breast carcinoma .e 1146 to 1238 11 to 104       94/109
(86 %)
5 diff
(95.5 %id)
CA431525 Alveolar Macrophage, lung .e 1146 to 1924 796 to 19   AAA   778/785
(99 %)
6 diff
(99.3 %id)
CB121974 Liver .e 1152 to 1634 2 to 484       483/484
(99 %)
0 diff
(100 %id)
DA442074 tongue, tumor tissue .e 1154 to 1711 2 to 559   tiling clone, capped   558/558
(100 %)
0 diff
(100 %id)
CB164671 Liver .e 1213 to 1747 1 to 535       535/535
(100 %)
0 diff
(100 %id)
AA654731   .e 1238 to 1729 1 to 492       492/523
(94 %)
17 diff
(96.8 %id)
FN113342 breast carcinoma .e 1249 to 1304 1 to 56       56/60
(93 %)
3 diff
(95.0 %id)
AW815389 stomach .e 1256 to 1767 514 to 3       512/521
(98 %)
3 diff
(99.5 %id)
AW469124 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .e 1303 to 1924 622 to 1       622/629
(98 %)
5 diff
(99.3 %id)
BE676383 B-cell, chronic lymphotic leukemia .e 1303 to 1925 623 to 1       623/689
(90 %)
17 diff
(97.6 %id)
AI628148 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .e 1304 to 1923 620 to 1       620/649
(95 %)
9 diff
(98.7 %id)
BU431448 lymph .e 1334 to 1594 1 to 264       264/264
(100 %)
20 diff
(92.5 %id)
AI248082 liver and spleen .e 1347 to 1924 581 to 1       561/581
(96 %)
10 diff
(98.3 %id)
DA601143   .e 1352 to 1937 2 to 588   capped   587/587
(100 %)
3 diff
(99.5 %id)
TI_149290898   .e 1379 to 2100 760 to 40       726/761
(95 %)
4 diff
(99.5 %id)
BU681944 lung .e 1399 to 2077 697 to 19   AAA   679/679
(100 %)
4 diff
(99.5 %id)
R06619 liver and spleen .e 1402 to 1771 1 to 369     Submitted on the opposite strand 369/369
(100 %)
16 diff
(95.7 %id)
AI193756 lung .e 1543 to 1924 382 to 1       382/407
(93 %)
7 diff
(98.3 %id)
BF093825 uterus .e 1563 to 1748 204 to 9       196/205
(95 %)
10 diff
(95.2 %id)
AI583330 bone marrow, CD34+, T negative, patient with chronicmyelogenous leukemia .e 1594 to 1761 1 to 167     Submitted on the opposite strand 167/167
(100 %)
11 diff
(93.5 %id)
FN172809 breast carcinoma .e 1606 to 1685 1 to 76       76/77
(98 %)
10 diff
(87.1 %id)
FN147945 breast carcinoma .e 1628 to 1723 1 to 95       95/102
(93 %)
4 diff
(96.1 %id)
FN131952 breast carcinoma .e 1646 to 1743 100 to 1     Submitted on the opposite strand 100/100
(100 %)
3 diff
(97.0 %id)
BU660230 blood .e 1650 to 2124 1 to 475   tiling clone,   475/475
(100 %)
2 diff
(99.6 %id)
H57839 liver and spleen .e 1666 to 1769 104 to 1       104/104
(100 %)
1 diff
(99.1 %id)
DA882988   .e 1930 to 2267 226 to 563   capped   338/562
(60 %)
0 diff
(100 %id)
BP210288 cerebellum .e 2005 to 2593 1 to 589   tiling clone,   589/589
(100 %)
0 diff
(100 %id)
BU430151 lymph .e 2247 to 2649 1 to 404       404/408
(99 %)
9 diff
(97.8 %id)
TI_154151465   .e 2253 to 2783 79 to 611       533/533
(100 %)
12 diff
(97.8 %id)
FN130038 breast carcinoma .e 2475 to 2542 1 to 69       69/78
(88 %)
4 diff
(94.9 %id)
BG548628 lung .e 2476 to 3226 1 to 754   tiling clone,   754/755
(99 %)
8 diff
(99.0 %id)
BU616570 Cell Line, Chondrosarcoma .e 2495 to 3165 689 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 671/671
(100 %)
1 diff
(99.9 %id)
BU508883 leiomyosarcoma, uterus .e 2540 to 3387 1 to 859       859/861
(99 %)
20 diff
(97.7 %id)
BU429086 lymph .e 2593 to 3032 1 to 440       440/440
(100 %)
8 diff
(98.2 %id)
TI_154148864   .e 2600 to 3325 66 to 793       728/728
(100 %)
24 diff
(96.8 %id)
TI_154150038   .e 2600 to 3316 80 to 786       707/772
(91 %)
43 diff
(94.5 %id)
DN995528 breast cancer, Mammary gland (cancer tissue) .e 2968 to 3558 10 to 601   tiling clone,   592/601
(98 %)
6 diff
(99.1 %id)
AK090565   .e 2985 to 5645 1 to 2661   tiling clone, available from FLJ,   2661/2661
(100 %)
12 diff
(99.6 %id)
AX746513   .e 2985 to 5645 1 to 2661       2661/2661
(100 %)
12 diff
(99.6 %id)
DA022662   .e 2986 to 3547 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
CU450876 epidermis .e 3229 to 3973 766 to 21     Submitted on the opposite strand 746/774
(96 %)
0 diff
(100 %id)
CU454354 epidermis .e 3266 to 3973 729 to 21     Submitted on the opposite strand 709/729
(97 %)
0 diff
(100 %id)
AA419515 germinal center B cell .e 3404 to 3759 1 to 357       357/357
(100 %)
5 diff
(98.6 %id)
DA356482 subthalamic nucleus .e 3406 to 3963 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
AA976314 2 pooled tumors (clear cell type), Kidney .e 3420 to 3782 383 to 21   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 363/363
(100 %)
0 diff
(100 %id)
T61961 lung .e 3665 to 3952 1 to 287   fully sequenced,   287/287
(100 %)
14 diff
(95.2 %id)
T61900 lung .e 3775 to 3963 194 to 1   fully sequenced,   194/194
(100 %)
2 diff
(99.0 %id)
BE152246 head_neck .e 4343 to 4958 618 to 2   tiling clone, Submitted on the opposite strand 617/618
(99 %)
0 diff
(100 %id)
BE152247 head_neck .e 4405 to 4979 586 to 18     Submitted on the opposite strand 569/591
(96 %)
0 diff
(100 %id)
CN272415 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .e 4535 to 5072 1 to 540       540/540
(100 %)
3 diff
(99.5 %id)
AW861436 colon .e 4725 to 5224 500 to 7       494/523
(94 %)
0 diff
(100 %id)
AI379494 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 4910 to 5646 717 to 1       717/951
(75 %)
22 diff
(97.7 %id)
CA312805 Human Lung Epithelial cells, lung .e 4923 to 5645 735 to 16   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 720/721
(99 %)
8 diff
(98.9 %id)
BF738143 bladder_tumor .e 5110 to 5492 393 to 11     Submitted on the opposite strand 383/393
(97 %)
0 diff
(100 %id)
DB310484 subthalamic nucleus .e 5113 to 5645 534 to 1       534/534
(100 %)
5 diff
(99.1 %id)
DB295593   .e 5120 to 5645 528 to 1       528/528
(100 %)
4 diff
(99.3 %id)
BE645594 Prostate .e 5123 to 5645 534 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 523/523
(100 %)
1 diff
(99.9 %id)
N21492 melanocyte .e 5144 to 5645 503 to 1       503/506
(99 %)
4 diff
(99.3 %id)
BQ030048 lung, Metastatic Chondrosarcoma .e 5159 to 5649 505 to 15       491/505
(97 %)
0 diff
(100 %id)
BF591652 carcinoid, lung .e 5177 to 5649 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
AI697755 carcinoid, lung .e 5188 to 5646 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
BF110435 carcinoid, lung .e 5191 to 5649 459 to 1       459/459
(100 %)
1 diff
(99.8 %id)
AW292293   .e 5195 to 5649 465 to 11       455/465
(97 %)
0 diff
(100 %id)
AI753335 bone marrow stroma .e 5206 to 5645 463 to 24   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 440/440
(100 %)
2 diff
(99.6 %id)
BE501763 Kidney .e 5209 to 5649 441 to 1       441/441
(100 %)
1 diff
(99.8 %id)
BX092752 adenocarcinoma, Pancreas .e 5219 to 5649 441 to 11   tiling clone,   431/441
(97 %)
0 diff
(100 %id)
AI880849 aorta .e 5225 to 5639 426 to 12       415/426
(97 %)
0 diff
(100 %id)
AI694169 adenocarcinoma, Pancreas .e 5226 to 5645 442 to 22   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 421/421
(100 %)
4 diff
(99.1 %id)
AW962119   .e 5255 to 5597 9 to 355       347/383
(90 %)
32 diff
(91.7 %id)
AA355198   .e 5257 to 5555 12 to 313       302/320
(94 %)
4 diff
(98.8 %id)
AW069124 bone marrow stroma .e 5291 to 5645 373 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 355/355
(100 %)
0 diff
(100 %id)
AW273377 serous papillary carcinoma, high grade, 2pooled tumors, uterus .e 5340 to 5642 303 to 1       303/303
(100 %)
2 diff
(99.4 %id)
AA923677 2 pooled tumors (clear cell type), Kidney .e 5406 to 5648 243 to 1       243/243
(100 %)
4 diff
(98.4 %id)
BC105960 PCR rescued clones .f 1 to 3009 1 to 3009 E489K tiling clone,   3009/3009
(100 %)
1 diff
(100.0 %id)
BC105744 PCR rescued clones .g 1 to 2910 1 to 2910 E456K tiling clone,   2910/2910
(100 %)
1 diff
(100.0 %id)
BC105743 PCR rescued clones .g 3 to 2910 1 to 2908 V397D E456K     2908/2908
(100 %)
2 diff
(100.0 %id)
DC392537 stomach .h 1 to 546 1 to 546   tiling clone,   546/546
(100 %)
1 diff
(99.9 %id)
AK301267 Spleen .h 2 to 2640 1 to 2639 E180G R273G K422E E440K K529R ... tiling clone,   2639/2639
(100 %)
9 diff
(99.7 %id)
DC391925 Spleen .h 2 to 526 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CD700509 normal nasopharynx .h 20 to 439 40 to 459       420/459
(91 %)
6 diff
(98.7 %id)
CD685469 normal nasopharynx .h 33 to 357 15 to 339       325/339
(95 %)
6 diff
(98.3 %id)
CD686065 normal nasopharynx .h 33 to 565 18 to 550       533/550
(96 %)
7 diff
(98.8 %id)
BU603042 mixed (pool of 40 RNAs) .h 33 to 686 1 to 659   tiling clone, available from MGC,   659/874
(75 %)
30 diff
(96.6 %id)
CA455286 mixed (pool of 40 RNAs) .h 33 to 353 1 to 321       321/838
(38 %)
5 diff
(99.5 %id)
DA932685 Spleen .h 39 to 603 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AA243335 germinal center B cell .h 74 to 491 12 to 427       416/427
(97 %)
9 diff
(97.9 %id)
AI435643 lymph node, lymphoma, follicular mixed small and largecell .h 967 to 1380 414 to 1   tiling clone,   414/415
(99 %)
7 diff
(98.4 %id)
AI865439 lymph node, lymphoma, follicular mixed small and largecell .h 1163 to 1380 218 to 1       218/218
(100 %)
0 diff
(100 %id)
BG677021 skin, squamous cell carcinoma .h 1218 to 2128 1 to 912       910/913
(99 %)
19 diff
(98.0 %id)
FN149972 breast carcinoma .h 1237 to 1303 67 to 1     Submitted on the opposite strand 67/70
(95 %)
0 diff
(100 %id)
EB388470 eye, optic nerve .h 1308 to 2132 1 to 825   tiling clone,   825/825
(100 %)
3 diff
(99.7 %id)
CB159840 Liver .h 1446 to 1968 1 to 523       523/523
(100 %)
0 diff
(100 %id)
BG026075 Bone, osteosarcoma, cell line .h 1533 to 2249 10 to 739       730/798
(91 %)
32 diff
(96.0 %id)
BU941540 mixed (pool of 40 RNAs) .h 1571 to 2368 1 to 805   tiling clone,   805/807
(99 %)
18 diff
(97.8 %id)
U63420 placenta .i 1 to 2898 1 to 2898 P186A E402K tiling clone,   2898/2905
(99 %)
7 diff
(99.8 %id)
CD369326 Alveolar Macrophage, lung .i 2297 to 2899 620 to 19   AAA   602/602
(100 %)
2 diff
(99.7 %id)
BG757090 B-cells, primary B-cells from tonsils (cell line) .i 2319 to 2899 1 to 581   AAA   581/581
(100 %)
3 diff
(99.5 %id)
TI_153987579   .i 2363 to 2899 620 to 84   AAA   537/537
(100 %)
3 diff
(99.5 %id)
AW203964   .i 2383 to 2899 534 to 18   AAA   517/517
(100 %)
3 diff
(99.5 %id)
AA832037 germinal center B cell .i 2409 to 2899 508 to 21   AAA   488/488
(100 %)
13 diff
(97.4 %id)
AA834545 germinal center B cell .i 2418 to 2898 491 to 11       481/491
(97 %)
0 diff
(100 %id)
BE831934 marrow .i 2423 to 2785 25 to 386       362/386
(93 %)
6 diff
(98.5 %id)
BE831984 marrow .i 2423 to 2867 446 to 1       446/446
(100 %)
4 diff
(99.2 %id)
BE831965 marrow .i 2425 to 2871 461 to 17       445/461
(96 %)
0 diff
(100 %id)
BF359868 marrow .i 2431 to 2686 263 to 7       257/263
(97 %)
0 diff
(100 %id)
AW592489 pooled .i 2433 to 2899 470 to 4       467/470
(99 %)
0 diff
(100 %id)
AI651609 pooled germ cell tumors .i 2467 to 2899 479 to 47   AAA   433/433
(100 %)
0 diff
(100 %id)
AI141093 lung .i 2475 to 2901 434 to 8   tiling clone,   427/434
(98 %)
0 diff
(100 %id)
AA252823 germinal center B cell .i 2481 to 2897 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
AI889899 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i 2506 to 2899 424 to 31   AAA   394/394
(100 %)
22 diff
(94.5 %id)
AA814841 germinal center B cell .i 2507 to 2731 225 to 1       225/225
(100 %)
0 diff
(100 %id)
BE831926 marrow .i 2516 to 2871 364 to 9       356/364
(97 %)
0 diff
(100 %id)
AA729002 germinal center B-cells, tonsil .i 2561 to 2899 348 to 10       339/348
(97 %)
0 diff
(100 %id)
U36501   .j 1 to 2198 1 to 2198 M686T tiling clone,   2198/2203
(99 %)
5 diff
(99.8 %id)
L79987   .j 1460 to 2194 1 to 735       735/735
(100 %)
2 diff
(99.8 %id)
AW205792   .j 1755 to 2196 457 to 16       442/467
(94 %)
1 diff
(99.8 %id)
AI720848 colon .j 1773 to 2198 428 to 3       426/428
(99 %)
0 diff
(100 %id)
AW590148 pooled germ cell tumors .j 1788 to 2194 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
AW590715 pooled germ cell tumors .j 1788 to 2194 407 to 1       407/407
(100 %)
0 diff
(100 %id)
AA884162 pooled .j 1796 to 2198 433 to 32       402/433
(92 %)
12 diff
(97.3 %id)
CB046447 2 pooled tumors (clear cell type), Kidney .j 1802 to 2192 10 to 400   fully sequenced, Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 391/400
(97 %)
10 diff
(97.5 %id)
CB046446 2 pooled tumors (clear cell type), Kidney .j 1958 to 2194 266 to 30   fully sequenced, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 237/237
(100 %)
0 diff
(100 %id)
AA888525 metastatic prostate bone lesion .j 1983 to 2196 15 to 228   tiling clone,   214/241
(88 %)
7 diff
(97.1 %id)
NM_138402.4   .k 1 to 2668 1 to 2668 exact RefSeq,   2668/2668
(100 %)
0 diff
(100 %id)
CN414563 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .k 5 to 353 1 to 349       349/350
(99 %)
3 diff
(99.2 %id)
BX480665   .k 5 to 599 1 to 595   tiling clone,   595/595
(100 %)
7 diff
(98.9 %id)
DA934525 Spleen .k 16 to 600 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
DB135451 thymus .k 16 to 570 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB140560 thymus .k 16 to 549 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
DB240458 trachea .k 16 to 606 2 to 592   tiling clone, capped   591/591
(100 %)
0 diff
(100 %id)
AW995280 breast_normal .k 399 to 642 244 to 2     Submitted on the opposite strand 243/244
(99 %)
0 diff
(100 %id)
BF082551 breast .k 399 to 642 241 to 1       241/241
(100 %)
5 diff
(98.0 %id)
GD136787   .k 487 to 580 8 to 101       94/102
(92 %)
11 diff
(89.3 %id)
AU130836   .k 605 to 1352 2 to 752   tiling clone, capped   750/755
(99 %)
17 diff
(97.8 %id)
BQ232706 embryonal carcinoma, cell line, testis .k 682 to 1466 1 to 788   tiling clone,   788/892
(88 %)
11 diff
(98.8 %id)
BF899205 marrow .k 906 to 1119 16 to 229       214/229
(93 %)
6 diff
(97.4 %id)
BF742262 breast .k 927 to 1240 31 to 344   tiling clone,   314/357
(87 %)
9 diff
(97.5 %id)
AW887813 ovary .k 1095 to 1642 1 to 548   tiling clone,   548/548
(100 %)
12 diff
(97.9 %id)
BQ690359 ductal carcinoma, cell line, Pancreas .k 1378 to 2268 1 to 902   tiling clone,   902/906
(99 %)
19 diff
(98.0 %id)
BX281497 large cell carcinoma, lung .k 1607 to 2086 1 to 480       480/480
(100 %)
0 diff
(100 %id)
CD636397   .k 1620 to 2137 1 to 518       518/518
(100 %)
0 diff
(100 %id)
CD636398   .k 1620 to 2137 516 to 1       516/516
(100 %)
2 diff
(99.7 %id)
BE787699 large cell carcinoma, lung .k 1628 to 2286 1 to 659       659/659
(100 %)
4 diff
(99.4 %id)
AW083450 colon, moderately differentiated adenocarcinoma .k 1647 to 1974 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
BG011068 placenta_normal .k 1678 to 1903 226 to 1       226/226
(100 %)
1 diff
(99.6 %id)
BE773476 prostate_tumor .k 1822 to 1981 1 to 160       160/160
(100 %)
2 diff
(98.8 %id)
BE811315 amnion_normal .k 1823 to 1986 169 to 9       161/169
(95 %)
0 diff
(100 %id)
BE811333 amnion_normal .k 1823 to 1981 1 to 159       159/159
(100 %)
0 diff
(100 %id)
BE811427 amnion_normal .k 1823 to 1991 173 to 9       165/173
(95 %)
0 diff
(100 %id)
CD636399   .k 1856 to 2137 1 to 281       281/281
(100 %)
6 diff
(97.9 %id)
CD636400   .k 1856 to 2137 282 to 1       282/282
(100 %)
5 diff
(98.3 %id)
BF030759 hypernephroma, Kidney .k 1958 to 2656 1 to 686       686/830
(82 %)
38 diff
(95.5 %id)
BQ000859 lung, Metastatic Chondrosarcoma .k 1973 to 2668 714 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 696/696
(100 %)
10 diff
(98.6 %id)
AA631047 normal prostate, Prostate .k 2081 to 2667 588 to 1   tiling clone,   588/588
(100 %)
1 diff
(99.9 %id)
AU152721   .k 2127 to 2668 535 to 1       535/535
(100 %)
18 diff
(96.7 %id)
CN360332 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 2208 to 2750 1 to 543   tiling clone,   543/543
(100 %)
2 diff
(99.7 %id)
AI620769 Prostate .k 2348 to 2669 322 to 1       322/322
(100 %)
0 diff
(100 %id)
DR979319 placenta .k 2375 to 2670 1 to 295     Submitted on the opposite strand 295/303
(97 %)
6 diff
(98.1 %id)
AI376101 uterus .k 2397 to 2668 272 to 1       272/440
(61 %)
0 diff
(100 %id)
GD157796   .k 2441 to 2666 1 to 227   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 227/230
(98 %)
18 diff
(92.2 %id)
BJ990889 hepatoblastoma .l 1 to 578 6 to 583   tiling clone,   583/583
(100 %)
0 diff
(100 %id)
BC011562 Kidney, renal cell adenocarcinoma .l 13 to 1793 1 to 1781 exact available from MGC, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1781/1781
(100 %)
1 diff
(100.0 %id)
AL554619 placenta, Placenta Cot 25-normalized .l 38 to 911 1 to 874       874/874
(100 %)
2 diff
(99.8 %id)
CR601757 Placenta Cot 25-normalized .l 42 to 1748 1 to 1707 exact tiling clone,   1707/1707
(100 %)
0 diff
(100 %id)
AL552735 placenta, Placenta Cot 25-normalized .l 42 to 858 1 to 815   fully sequenced,   815/815
(100 %)
1 diff
(99.9 %id)
AL545142 placenta, Placenta Cot 25-normalized .l 52 to 911 1 to 862       862/862
(100 %)
1 diff
(99.9 %id)
AL554153 placenta, Placenta Cot 25-normalized .l 52 to 989 1 to 929   fully sequenced,   929/929
(100 %)
3 diff
(99.7 %id)
M60618 Liver .l 61 to 1939 1 to 1879 exact     1879/1879
(100 %)
2 diff
(99.9 %id)
AA125878 uterus .l 280 to 722 1 to 455       450/460
(97 %)
15 diff
(96.8 %id)
W49737 senescent fibroblast .l 515 to 1000 1 to 489     Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 489/489
(100 %)
6 diff
(98.8 %id)
AA001323 liver and spleen .l 526 to 1148 1 to 625       625/626
(99 %)
7 diff
(98.9 %id)
BF688611 eye, normal pigmented retinal epithelium .l 701 to 1263 1 to 560   fully sequenced,   560/560
(100 %)
4 diff
(99.3 %id)
BQ930623 epidermoid carcinoma, cell line, lung .l 738 to 1667 1 to 941       941/950
(99 %)
30 diff
(96.9 %id)
AL575938 placenta, Placenta Cot 25-normalized .l 797 to 1748 951 to 1   fully sequenced,   951/951
(100 %)
4 diff
(99.6 %id)
TI_57230081   .l 797 to 1678 99 to 985       887/898
(98 %)
24 diff
(97.4 %id)
BI870620 adenocarcinoma, cell line, Liver .l 798 to 1678 1 to 886       886/897
(98 %)
24 diff
(97.4 %id)
BX370498   .l 863 to 1728 1 to 887       887/1005
(88 %)
99 diff
(90.2 %id)
BM551379 melanotic melanoma, skin .l 873 to 1839 1 to 972       972/1036
(93 %)
22 diff
(97.9 %id)
AL577611 placenta .l 906 to 1881 1003 to 30       974/1009
(96 %)
10 diff
(99.1 %id)
TI_149303537   .l 906 to 1781 957 to 93   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 865/956
(90 %)
15 diff
(98.5 %id)
AL571086 placenta, Placenta Cot 25-normalized .l 912 to 1753 845 to 1       845/845
(100 %)
31 diff
(96.4 %id)
AL577258 placenta, Placenta Cot 25-normalized .l 912 to 1909 998 to 1       998/998
(100 %)
11 diff
(98.9 %id)
BG290755 bladder, transitional cell papilloma, cell line .l 932 to 1741 1 to 816       816/917
(88 %)
30 diff
(96.8 %id)
TI_154115508   .l 941 to 1781 910 to 79   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 832/965
(86 %)
15 diff
(98.5 %id)
AA059485 cornea .l 950 to 1477 1 to 519   fully sequenced,   519/519
(100 %)
1 diff
(99.9 %id)
AL576953 placenta, Placenta Cot 25-normalized .l 959 to 1713 786 to 33   fully sequenced,   754/786
(95 %)
21 diff
(97.4 %id)
TI_149311406   .l 977 to 1947 1042 to 84   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 959/967
(99 %)
27 diff
(97.3 %id)
BQ001566 lung, Metastatic Chondrosarcoma .l 979 to 1781 818 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 800/800
(100 %)
7 diff
(99.2 %id)
CA449228 Chondrosarcoma, Left Pubic Bone .l 980 to 1781 815 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 797/797
(100 %)
8 diff
(99.0 %id)
BG168608 hypernephroma, cell line, Kidney .l 991 to 1663 1 to 705       608/1200
(50 %)
47 diff
(96.1 %id)
BQ673647 epidermoid carcinoma, cell line, salivary gland .l 999 to 1781 18 to 801   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 784/801
(97 %)
11 diff
(98.7 %id)
TI_149277439   .l 1002 to 1708 792 to 86   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 707/708
(99 %)
4 diff
(99.5 %id)
BU677671 lung .l 1022 to 1708 703 to 17   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 687/687
(100 %)
2 diff
(99.8 %id)
BM981532 lung, Primary Lung Cystic Fibrosis EpithelialCells .l 1035 to 1781 763 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 745/745
(100 %)
4 diff
(99.5 %id)
BG655976 Pancreas, Purified pancreatic islet .l 1044 to 1601 21 to 578       558/580
(96 %)
29 diff
(95.0 %id)
BE619940 large cell carcinoma, lung .l 1063 to 1888 839 to 3       837/850
(98 %)
19 diff
(97.8 %id)
AI347058 adenocarcinoma, colon .l 1076 to 1942 866 to 3       864/866
(99 %)
23 diff
(97.4 %id)
CD370208 Alveolar Macrophage, lung .l 1087 to 1781 712 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 694/694
(100 %)
3 diff
(99.6 %id)
BU623040 cell lines, Chondrosarcoma .l 1093 to 1793 715 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 697/697
(100 %)
4 diff
(99.5 %id)
AI935011 pooled .l 1115 to 1784 671 to 2       670/671
(99 %)
3 diff
(99.6 %id)
BU619970 cell lines, Chondrosarcoma .l 1123 to 1781 676 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 658/658
(100 %)
2 diff
(99.7 %id)
BQ008697 Chondrosarcoma, Left Pelvis .l 1128 to 1781 672 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BM989176 Fibrosarcoma .l 1128 to 1781 672 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 654/654
(100 %)
2 diff
(99.7 %id)
BU632470 cell lines, Chondrosarcoma .l 1128 to 1781 672 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 654/654
(100 %)
1 diff
(99.9 %id)
BQ189396 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .l 1134 to 1663 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
TI_151731678   .l 1134 to 1793 743 to 78   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 666/1006
(66 %)
6 diff
(99.5 %id)
AI479111 B-cell, chronic lymphotic leukemia .l 1138 to 1794 657 to 1       657/657
(100 %)
7 diff
(99.0 %id)
AA009479 liver and spleen .l 1147 to 1490 1 to 351       351/375
(93 %)
10 diff
(97.4 %id)
BF689000 eye, normal pigmented retinal epithelium .l 1202 to 1728 526 to 1   fully sequenced,   526/526
(100 %)
3 diff
(99.5 %id)
AA057395.
matches multiple genes
cornea .l 1228 to 1782 555 to 1     also hits gene RARRES2 555/637
(87 %)
11 diff
(98.3 %id)
AI925539 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .l 1228 to 1781 569 to 15   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 555/617
(89 %)
3 diff
(99.6 %id)
BM981268 lung, Primary Lung Cystic Fibrosis EpithelialCells .l 1228 to 1939 730 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 712/712
(100 %)
3 diff
(99.6 %id)
AI683333 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 1230 to 1781 589 to 36   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 552/644
(85 %)
27 diff
(95.9 %id)
AA740520 2 pooled tumors (clear cell type), Kidney .l 1231 to 1782 555 to 5       551/654
(84 %)
19 diff
(97.1 %id)
BM876634 insulinoma, Pancreas .l 1244 to 1785 549 to 8     Submitted on the opposite strand 542/549
(98 %)
1 diff
(99.9 %id)
BQ010561 placenta .l 1251 to 1781 548 to 18   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 531/531
(100 %)
1 diff
(99.9 %id)
AI805718 serous papillary carcinoma, high grade, 2pooled tumors, uterus .l 1252 to 1782 534 to 6       529/534
(99 %)
2 diff
(99.7 %id)
BM997454 lung, Metastatic Chondrosarcoma .l 1257 to 1939 700 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 682/682
(100 %)
1 diff
(99.9 %id)
BQ017208 lung, Metastatic Chondrosarcoma .l 1258 to 1939 700 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 682/682
(100 %)
1 diff
(99.9 %id)
AA001910 liver and spleen .l 1336 to 1782 450 to 1       450/450
(100 %)
4 diff
(99.2 %id)
AW363532 colon .l 1371 to 1797 431 to 2       428/431
(99 %)
2 diff
(99.6 %id)
BJ990890 hepatoblastoma .l 1381 to 1919 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
AA917748 adenocarcinoma, colon .l 1443 to 1942 502 to 3       500/502
(99 %)
0 diff
(100 %id)
AA058910 cornea .l 1447 to 1940 492 to 1   fully sequenced,   492/492
(100 %)
10 diff
(98.0 %id)
AA772967   .l 1502 to 1846 353 to 1       353/353
(100 %)
22 diff
(93.8 %id)
W49635 senescent fibroblast .l 1503 to 1949 459 to 12   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 448/449
(99 %)
2 diff
(99.6 %id)
AA810108 germinal center B cell .l 1514 to 1957 452 to 9   tiling clone,   444/452
(98 %)
0 diff
(100 %id)
AI302230 2 pooled tumors (clear cell type), Kidney .l 1515 to 1947 436 to 4       433/436
(99 %)
0 diff
(100 %id)
FN164964 breast carcinoma .l 1520 to 1605 93 to 6     Submitted on the opposite strand 88/93
(94 %)
0 diff
(100 %id)
AA125879 uterus .l 1521 to 1949 429 to 1       429/429
(100 %)
0 diff
(100 %id)
AA558802 breast .l 1524 to 1949 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AW474155 lymph node, lymphoma, follicular mixed small and largecell .l 1524 to 1940 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AW363523 colon .l 1526 to 1858 335 to 1       335/335
(100 %)
0 diff
(100 %id)
AI867030 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .l 1527 to 1943 417 to 1       417/426
(97 %)
1 diff
(99.8 %id)
AI805202 Prostate .l 1537 to 1939 415 to 13   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 403/403
(100 %)
2 diff
(99.6 %id)
AA120878 uterus .l 1550 to 1741 192 to 1     Submitted on the opposite strand 192/192
(100 %)
1 diff
(99.5 %id)
AI625074 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .l 1557 to 1941 380 to 1       380/380
(100 %)
9 diff
(97.7 %id)
BE858854 Prostate .l 1562 to 1949 388 to 1       388/388
(100 %)
1 diff
(99.8 %id)
AI084722 senescent fibroblast .l 1568 to 1939 388 to 16   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 373/373
(100 %)
1 diff
(99.8 %id)
AA857202 adenocarcinoma, colon .l 1580 to 1942 364 to 3       362/364
(99 %)
0 diff
(100 %id)
BU535209 mixed (pool of 40 RNAs) .l 1582 to 1937 1 to 356       356/392
(90 %)
7 diff
(98.3 %id)
N30802 placenta .l 1593 to 1937 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AI872666 adenocarcinoma, Pancreas .l 1603 to 1951 351 to 1       351/358
(98 %)
6 diff
(98.4 %id)
BF326804 breast_normal .l 1620 to 1943 323 to 2       322/323
(99 %)
0 diff
(100 %id)
R06677 liver and spleen .l 1651 to 1950 301 to 1     Submitted on the opposite strand 301/304
(99 %)
5 diff
(98.4 %id)
D57330   .l 1670 to 1939 1 to 271       271/271
(100 %)
4 diff
(98.6 %id)
R26749 placenta .l 1684 to 1949 267 to 1       267/267
(100 %)
1 diff
(99.7 %id)
EH340881   .l 1697 to 1773 1 to 76       76/76
(100 %)
1 diff
(98.7 %id)
AA009766 liver and spleen .l 1727 to 1937 214 to 1       214/239
(89 %)
10 diff
(95.9 %id)
CR613678 HeLa cells Cot 25-normalized .m 1 to 1802 1 to 1802 exact tiling clone,   1802/1802
(100 %)
0 diff
(100 %id)
N43008 melanocyte .m 14 to 431 1 to 420       420/527
(79 %)
13 diff
(97.6 %id)
N33346 melanocyte .m 1405 to 1830 428 to 1   tiling clone,   428/429
(99 %)
4 diff
(99.1 %id)
AK293373 bladder .n 1 to 1846 1 to 1846 R22M Q377H tiling clone,   1846/1846
(100 %)
3 diff
(99.9 %id)
DC301019 bladder .n 1 to 526 1 to 527       527/527
(100 %)
3 diff
(99.5 %id)
DC297616   .n 2 to 502 1 to 501       501/501
(100 %)
3 diff
(99.5 %id)
DC358547 lung .n 2 to 619 1 to 617       617/617
(100 %)
1 diff
(99.9 %id)
DC390330 Spleen .n 2 to 569 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BM459672 leiomyosarcoma, uterus .n 12 to 646 1 to 635   tiling clone,   635/945
(67 %)
3 diff
(99.7 %id)
BE619408 large cell carcinoma, lung .n 18 to 741 1 to 728       728/802
(90 %)
22 diff
(97.3 %id)
AL555004 placenta .n 22 to 969 1 to 930       930/934
(99 %)
20 diff
(97.9 %id)
BQ073446 epidermoid carcinoma, cell line, lung .n 50 to 274 1 to 225       225/1180
(19 %)
1 diff
(100.0 %id)
BG215709   .n 821 to 1588 1 to 760   tiling clone,   760/766
(99 %)
18 diff
(97.7 %id)
AA040474 uterus .n 864 to 1200 1 to 339       337/381
(88 %)
5 diff
(98.7 %id)
BE675052 B-cell, chronic lymphotic leukemia .n 1267 to 1849 593 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 583/583
(100 %)
0 diff
(100 %id)
AA045491 uterus .n 1432 to 1842 414 to 1       414/415
(99 %)
4 diff
(99.1 %id)
AK091898 Kidney .o 1 to 2023 2 to 2024 S212P tiling clone, available from FLJ,   2024/2024
(100 %)
2 diff
(100.0 %id)
DA627829 Kidney .o 1 to 555 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BP342626 stomach mucosa .o 209 to 787 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DB320713 Kidney .o 1471 to 2023 553 to 1       553/555
(99 %)
0 diff
(100 %id)
DA075302 cerebellum .p 1 to 562 2 to 567   tiling clone, capped   566/566
(100 %)
5 diff
(99.2 %id)
CT003268 T-Lymphocytes .p 437 to 1259 1 to 824   tiling clone,   824/829
(99 %)
7 diff
(99.2 %id)
AK304205 trachea .q 1 to 1214 8 to 1221 S359G tiling clone,   1221/1221
(100 %)
3 diff
(99.8 %id)
DA541917 lung .q 687 to 1259 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
CB269486 adipose .q 1159 to 1680 1 to 521   tiling clone,   521/521
(100 %)
6 diff
(98.9 %id)
BY996301   .r 1 to 639 1 to 638   tiling clone,   638/638
(100 %)
6 diff
(99.1 %id)
L79989   .r 630 to 1191 1 to 560   tiling clone,   560/560
(100 %)
1 diff
(99.9 %id)
AI025130 breast .r 772 to 1190 419 to 1   tiling clone,   419/419
(100 %)
1 diff
(99.8 %id)
FN083331 breast carcinoma .r 810 to 873 1 to 64       64/64
(100 %)
3 diff
(95.4 %id)
AK023116   .s 1 to 3078 2 to 3079 M52T tiling clone, available from FLJ,   3079/3079
(100 %)
5 diff
(99.9 %id)
DA878024 Prostate .s 614 to 1182 2 to 571   tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DA386212 thalamus .s 1172 to 1722 2 to 552   tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
AW797504 uterus .t 1 to 261 264 to 1   tiling clone,   263/267
(98 %)
1 diff
(99.7 %id)
BX445010 brain, fetal brain .t 214 to 1103 893 to 8   tiling clone,   886/893
(99 %)
3 diff
(99.7 %id)
BX413429 brain, fetal brain .t 532 to 1129 598 to 1   tiling clone,   598/598
(100 %)
30 diff
(95.0 %id)
TI_1241113083   .u 1 to 744 51 to 794 exact tiling clone,   744/1275
(58 %)
7 diff
(99.5 %id)
TI_1241113467   .u 1 to 744 814 to 71 exact     744/1288
(57 %)
0 diff
(100 %id)
TI_2194628689   .u 1 to 742 45 to 786 exact     742/1285
(57 %)
7 diff
(99.5 %id)
TI_2194629069   .u 1 to 742 810 to 69 exact     742/1296
(57 %)
0 diff
(100 %id)
TI_2194629435   .u 1 to 742 48 to 789 exact     742/1268
(58 %)
10 diff
(99.3 %id)
TI_2194629437   .u 1 to 742 45 to 786 exact     742/1237
(59 %)
7 diff
(99.5 %id)
TI_2194629439   .u 1 to 742 811 to 70 exact     742/1202
(61 %)
0 diff
(100 %id)
TI_2194629441   .u 1 to 742 810 to 69 exact     742/1170
(63 %)
1 diff
(100.0 %id)
BC105007 Brain, cerebral cortex and lung, PCR rescuedclones .u 1 to 742 1 to 742 exact     742/742
(100 %)
0 diff
(100 %id)
BC143624 Brain, cerebral cortex and lung, PCR rescuedclones .u 1 to 742 1 to 742 exact     742/742
(100 %)
0 diff
(100 %id)
CN363112 embryonic stem cells, cell lines H1, H7, andH9 .va 1 to 669 1 to 669 N183* tiling clone,   669/669
(100 %)
2 diff
(99.8 %id)
DC339374 subthalamic nucleus .va 13 to 581 1 to 569   tiling clone,   569/569
(100 %)
2 diff
(99.7 %id)
BP261695 small intestine .va 17 to 598 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CB163656 Liver .vb-u 1 to 535 11 to 545 E174Q D176E E177K tiling clone,   535/585
(91 %)
4 diff
(99.4 %id)
NM_001005176.2   .vc 1 to 835 1 to 835 exact RefSeq, AAA   835/835
(100 %)
0 diff
(100 %id)
BU537543 mixed (pool of 40 RNAs) .vc 32 to 691 1 to 664 E29* tiling clone,   664/777
(85 %)
24 diff
(97.0 %id)
BC070160 Pooled, 40 cell lines .vc 35 to 835 1 to 801 exact tiling clone, AAA   801/801
(100 %)
1 diff
(99.9 %id)
AA741304 germinal center B cell .vc 344 to 835 511 to 20   AAA   492/492
(100 %)
0 diff
(100 %id)
AI312990 bone marrow, stem cell 34+/38+ .vc 642 to 835 38 to 229   AAA Submitted on the opposite strand 192/229
(83 %)
9 diff
(96.1 %id)
CR987282 T-Lymphocytes .vd 1 to 751 1 to 751 exact tiling clone,   751/756
(99 %)
1 diff
(99.9 %id)
AA361548   .vd 624 to 984 1 to 361   tiling clone,   361/361
(100 %)
0 diff
(100 %id)
AW955438   .vd 625 to 1084 1 to 459   tiling clone,   459/459
(100 %)
4 diff
(99.2 %id)
AA278203 germinal center B cell .ve 1 to 487 1 to 481   tiling clone,   481/481
(100 %)
6 diff
(98.8 %id)
AV760490 bone marrow .vf 1 to 555 7 to 554 L126F N127E E128I I129T Y130E ... tiling clone,   554/700
(79 %)
9 diff
(98.8 %id)
CB112175 Liver .vg 1 to 628 1 to 629 R48* tiling clone,   629/636
(98 %)
5 diff
(99.3 %id)
BM809619 amelanotic melanoma, cell line, skin .vh 1 to 925 22 to 955 E116X tiling clone, AAA   934/955
(97 %)
25 diff
(97.4 %id)
AA259138 germinal center B cell .vh 481 to 735 257 to 3       255/257
(99 %)
1 diff
(99.7 %id)
BX100832 aorta .vh 523 to 783 26 to 287       262/287
(91 %)
10 diff
(96.6 %id)
AI719324 aorta .vh 539 to 927 389 to 1   tiling clone,   389/389
(100 %)
2 diff
(99.5 %id)
BX955263   .vi 1 to 463 1 to 463 E53K tiling clone,   463/463
(100 %)
1 diff
(99.8 %id)
R01630 liver and spleen .vj 1 to 304 5 to 316   tiling clone,   312/356
(87 %)
17 diff
(95.3 %id)
T95573 liver and spleen .vj 9 to 295 1 to 291       291/291
(100 %)
4 diff
(98.7 %id)
W86694 liver and spleen .vj 9 to 378 1 to 374   tiling clone,   374/398
(93 %)
5 diff
(98.8 %id)
W86620 liver and spleen .vj 404 to 818 416 to 1   tiling clone,   416/416
(100 %)
1 diff
(99.8 %id)
R01631 liver and spleen .vj 499 to 793 305 to 1       305/336
(90 %)
17 diff
(95.0 %id)
T95574 liver and spleen .vj 538 to 794 257 to 1   tiling clone,   257/257
(100 %)
0 diff
(100 %id)
BE926221 breast_normal .vk 1 to 397 398 to 1 E2R S3I E4I E5R M6N ... tiling clone,   398/471
(84 %)
4 diff
(99.2 %id)
AU185691 skin .vk 181 to 394 214 to 1       214/214
(100 %)
0 diff
(100 %id)
TI_149302021   .vl 1 to 640 716 to 80 N5I N6M D7T N8T P9F ... AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 635/784
(80 %)
20 diff
(97.5 %id)
TI_149297778   .vl 4 to 798 876 to 93   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 784/943
(83 %)
18 diff
(98.1 %id)
TI_159721620   .vl 7 to 808 904 to 109   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 796/1017
(78 %)
13 diff
(98.8 %id)
TI_149313532   .vl 11 to 808 883 to 90   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 794/997
(79 %)
13 diff
(98.7 %id)
BI259672 cervical carcinoma cell line, cervix .vl 18 to 640 1 to 623   tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 623/623
(100 %)
4 diff
(99.4 %id)
AA447481   .vl 42 to 464 1 to 423   fully sequenced,   423/423
(100 %)
2 diff
(99.6 %id)
BE044254 pooled .vl 44 to 643 620 to 9       612/620
(98 %)
4 diff
(99.4 %id)
TI_149298032   .vl 46 to 798 835 to 86   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 750/908
(82 %)
10 diff
(98.9 %id)
TI_149303220   .vl 46 to 798 818 to 68   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 751/944
(79 %)
9 diff
(99.1 %id)
BM983006 lung, Primary Lung Cystic Fibrosis EpithelialCells .vl 46 to 798 768 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 750/766
(97 %)
10 diff
(98.7 %id)
CB052331 leiomyosarcoma, soft tissue .vl 54 to 643 635 to 46   AAA   590/599
(98 %)
2 diff
(99.7 %id)
BM977324 lung, Primary Lung Cystic Fibrosis EpithelialCells .vl 62 to 806 763 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 745/745
(100 %)
5 diff
(99.4 %id)
BM982788 lung, Primary Lung Cystic Fibrosis EpithelialCells .vl 68 to 798 747 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 729/729
(100 %)
6 diff
(99.2 %id)
CD366515 Alveolar Macrophage, lung .vl 69 to 798 746 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 728/728
(100 %)
3 diff
(99.6 %id)
BQ446027 Knee, Osteoarthritic Cartilage .vl 70 to 798 747 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 729/729
(100 %)
4 diff
(99.5 %id)
H59542 liver and spleen .vl 139 to 461 1 to 327       327/351
(93 %)
11 diff
(96.9 %id)
W25428 senescent fibroblast .vl 144 to 241 7 to 104       98/116
(84 %)
3 diff
(97.5 %id)
AA632345 breast .vl 144 to 640 498 to 1       498/587
(84 %)
8 diff
(98.7 %id)
AI425046 pooled .vl 144 to 813 670 to 1       670/732
(91 %)
8 diff
(99.0 %id)
AW182401 pooled .vl 144 to 641 499 to 2       498/506
(98 %)
9 diff
(98.3 %id)
AI379485 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .vl 147 to 640 494 to 1       494/494
(100 %)
1 diff
(99.8 %id)
AI918021 Prostate .vl 152 to 811 660 to 3   tiling clone,   658/660
(99 %)
5 diff
(99.3 %id)
AA993907 pooled .vl 154 to 639 490 to 1       490/498
(98 %)
23 diff
(95.4 %id)
TI_157609418   .vl 159 to 640 572 to 86   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 487/642
(75 %)
8 diff
(98.8 %id)
AI245520 Kidney .vl 165 to 641 472 to 4       469/472
(99 %)
15 diff
(96.9 %id)
AA740339 2 pooled tumors (clear cell type), Kidney .vl 166 to 641 482 to 5       478/482
(99 %)
14 diff
(97.1 %id)
N41576.
matches multiple genes
placenta .vl 167 to 415 1 to 253     also hits gene flyzerbo, kisaya, madu, smeesporbu 253/261
(96 %)
6 diff
(97.8 %id)
BM980291 lung, Primary Lung Cystic Fibrosis EpithelialCells .vl 171 to 640 488 to 19   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 470/470
(100 %)
2 diff
(99.6 %id)
AW151322 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .vl 172 to 798 627 to 1       627/627
(100 %)
10 diff
(98.5 %id)
BE826175 lung_normal .vl 175 to 621 17 to 461       445/469
(94 %)
9 diff
(98.1 %id)
AW512714 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .vl 187 to 808 634 to 11   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 624/624
(100 %)
4 diff
(99.4 %id)
AW945713 lung_normal .vl 188 to 616 438 to 11     Submitted on the opposite strand 428/438
(97 %)
1 diff
(99.8 %id)
AI911765 pooled .vl 193 to 641 452 to 4       449/452
(99 %)
1 diff
(99.8 %id)
BF935412 nervous_tumor .vl 195 to 448 257 to 4     Submitted on the opposite strand 254/257
(98 %)
1 diff
(99.7 %id)
BI439602 Pancreas, Purified pancreatic islet .vl 205 to 808 615 to 12   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 604/604
(100 %)
3 diff
(99.6 %id)
CB250667 Human Lung Epithelial cells, lung .vl 217 to 638 441 to 20   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
AI040538 liver and spleen .vl 218 to 810 586 to 1       584/586
(99 %)
21 diff
(96.5 %id)
AW754061 colon .vl 237 to 716 547 to 62       486/556
(87 %)
2 diff
(99.7 %id)
AA693648 liver and spleen .vl 240 to 481 243 to 1       243/287
(84 %)
9 diff
(96.9 %id)
AA588342 colon, colon tumor RER+ .vl 241 to 638 397 to 1       397/398
(99 %)
22 diff
(94.5 %id)
AW604637 colon .vl 244 to 780 539 to 1       537/539
(99 %)
17 diff
(96.9 %id)
AI242044 liver and spleen .vl 253 to 800 548 to 1       548/548
(100 %)
1 diff
(99.9 %id)
AI032077 liver and spleen .vl 265 to 810 543 to 1       541/543
(99 %)
11 diff
(98.0 %id)
AI753406 bone marrow stroma .vl 272 to 652 400 to 20   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 381/381
(100 %)
0 diff
(100 %id)
AI147121 pooled .vl 282 to 811 531 to 2       530/531
(99 %)
0 diff
(100 %id)
AW363136 colon .vl 283 to 798 521 to 5       517/521
(99 %)
0 diff
(100 %id)
AV748705 Pituitary .vl 286 to 594 309 to 1     Submitted on the opposite strand 309/545
(56 %)
0 diff
(100 %id)
BX399238 Placenta Cot 25-normalized .vl 296 to 780 485 to 1       485/671
(72 %)
9 diff
(98.7 %id)
AA928288 pharynx, squamous cell carcinoma .vl 296 to 808 513 to 1       513/517
(99 %)
5 diff
(99.1 %id)
AA903332 leiomyosarcoma, soft tissue .vl 296 to 796 499 to 1       499/599
(83 %)
91 diff
(84.9 %id)
DB375922 placenta .vl 296 to 808 515 to 1       515/564
(91 %)
12 diff
(97.9 %id)
AI018222 pooled .vl 299 to 815 517 to 1   tiling clone,   517/517
(100 %)
2 diff
(99.7 %id)
AA845656 Spleen .vl 328 to 796 471 to 1       471/471
(100 %)
23 diff
(95.2 %id)
R36647 placenta .vl 340 to 619 283 to 1       283/286
(98 %)
7 diff
(97.6 %id)
BG994936 head_neck .vl 344 to 583 1 to 246       246/287
(85 %)
15 diff
(94.8 %id)
DB516408 testis .vl 349 to 806 1 to 458     Submitted on the opposite strand 458/460
(99 %)
1 diff
(99.8 %id)
AI874088 serous papillary carcinoma, high grade, 2pooled tumors, uterus .vl 355 to 640 302 to 17   AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 286/303
(94 %)
5 diff
(98.4 %id)
W19234 senescent fibroblast .vl 357 to 811 469 to 4       466/469
(99 %)
0 diff
(100 %id)
AA506003 breast .vl 365 to 798 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
AA447482   .vl 434 to 812 379 to 1   fully sequenced,   379/379
(100 %)
1 diff
(99.8 %id)
H60412 liver and spleen .vl 543 to 807 269 to 3       267/269
(99 %)
0 diff
(100 %id)
CB160763 Liver .vm 1 to 488 2 to 489 exact tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 488/489
(99 %)
0 diff
(100 %id)
BG335812 choriocarcinoma, placenta .vn 1 to 683 1 to 681 L35W E36K A37H L38C F39S ... tiling clone,   681/985
(69 %)
10 diff
(99.0 %id)
BG335937 choriocarcinoma, placenta .vn 1 to 703 1 to 696 L35W E36K A37H L38C F39S ...     696/961
(72 %)
18 diff
(98.2 %id)
BG480402 choriocarcinoma, placenta .vn 1 to 420 1 to 435       435/522
(83 %)
16 diff
(97.0 %id)
BC004921 Placenta, choriocarcinoma .vn 2 to 1708 1 to 1707 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 1707/1707
(100 %)
0 diff
(100 %id)
BE278323 choriocarcinoma, placenta .vn 10 to 636 1 to 623   available from MGC,   623/625
(99 %)
22 diff
(96.5 %id)
BX092577 Prostate .vn 732 to 1055 1 to 324   AAA   324/324
(100 %)
0 diff
(100 %id)
AA688226 normal prostate, Prostate .vn 763 to 1048 286 to 1       286/286
(100 %)
0 diff
(100 %id)
AI810878 Prostate .vn 765 to 1048 284 to 1       284/284
(100 %)
0 diff
(100 %id)
AI810978 Prostate .vn 765 to 1048 284 to 1       284/284
(100 %)
0 diff
(100 %id)
BF002973 Prostate .vn 765 to 1051 287 to 1       287/287
(100 %)
0 diff
(100 %id)
DN995589 breast cancer, Mammary gland (cancer tissue) .vo 1 to 649 1 to 649 exact tiling clone,   649/649
(100 %)
3 diff
(99.6 %id)
BF509142   .vp 1 to 736 750 to 18   tiling clone, AAA   733/744
(98 %)
8 diff
(99.0 %id)
AK160379 Spleen .vp 181 to 5025 1 to 4845 M59T tiling clone, available from FLJ,   4845/4845
(100 %)
14 diff
(99.8 %id)
AK126529 uterus .vq 1 to 3720 2 to 3732 M59T tiling clone, available from FLJ,   3732/3732
(100 %)
23 diff
(99.4 %id)
DB282293 uterus .vq 1 to 540 2 to 544   capped   543/543
(100 %)
3 diff
(99.5 %id)
AI908331 breast .vq 1524 to 2128 607 to 1       607/607
(100 %)
14 diff
(97.7 %id)
DB352575 uterus .vq 3173 to 3720 550 to 1 M59T tiling clone,   550/550
(100 %)
4 diff
(99.3 %id)
AL597306   .vr-u 1 to 602 1 to 602 exact tiling clone,   602/602
(100 %)
0 diff
(100 %id)
BU656263 blood .vs 1 to 550 9 to 558 R23L Q53H tiling clone,   550/558
(98 %)
10 diff
(98.3 %id)
BG722415 testis .vs 256 to 1051 1 to 796   tiling clone,   796/800
(99 %)
12 diff
(98.5 %id)
BG722250 testis .vs 256 to 1170 1 to 910   tiling clone,   910/910
(100 %)
17 diff
(98.2 %id)
BI560481 testis .vs 256 to 1053 1 to 807   tiling clone,   807/807
(100 %)
17 diff
(97.9 %id)
TI_44349456   .vs 261 to 1053 123 to 924       802/924
(86 %)
18 diff
(98.1 %id)
DB091627 testis .vs 280 to 836 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DB091665 testis .vs 280 to 834 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA209738 brain .vt 1 to 565 2 to 566 exact tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
DB027885 testis .vu 1 to 590 2 to 593 exact tiling clone, capped   592/592
(100 %)
3 diff
(99.5 %id)
BG708117 brain, hypothalamus .vv 1 to 773 1 to 768 L10* tiling clone,   768/769
(99 %)
12 diff
(98.5 %id)
DA962037 Spleen .vw 1 to 573 2 to 554 exact tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
BM828576 Ascites, stomach .vw 123 to 521 1 to 379   tiling clone,   379/379
(100 %)
1 diff
(99.8 %id)
BQ720853 sympathetic trunk .vx 1 to 864 1 to 864   tiling clone,   864/867
(99 %)
12 diff
(98.7 %id)
DB115490 thymus .vx 110 to 680 2 to 573   capped   572/572
(100 %)
6 diff
(99.0 %id)
DA922800 small intestine .vx 596 to 1158 2 to 567   tiling clone, capped   566/566
(100 %)
3 diff
(99.5 %id)
CB047248 Kidney .vx 930 to 1490 10 to 570 exact tiling clone,   561/570
(98 %)
11 diff
(98.1 %id)
BF515944   .vx 945 to 1539 612 to 18 exact tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 595/595
(100 %)
0 diff
(100 %id)
DC396175 testis .vy 1 to 580 1 to 580   tiling clone,   580/580
(100 %)
2 diff
(99.7 %id)
AA281823 germinal center B cell .vy 418 to 728 1 to 309   tiling clone,   309/309
(100 %)
7 diff
(97.8 %id)
AA404969 germinal center B cell .vy 859 to 1350 492 to 1   tiling clone,   492/492
(100 %)
2 diff
(99.6 %id)
AW847767 colon .vz 1 to 498 1 to 498   tiling clone,   498/593
(83 %)
3 diff
(99.5 %id)
AA278237 germinal center B cell .vz 131 to 449 1 to 319       319/319
(100 %)
0 diff
(100 %id)
BQ364978 stomach_normal .vz 226 to 734 8 to 519       512/519
(98 %)
6 diff
(98.9 %id)
CF597051 ovary .vz 375 to 906 1 to 541   tiling clone,   541/1105
(48 %)
22 diff
(98.1 %id)
AA278695 germinal center B cell .vz 517 to 1003 486 to 1   tiling clone,   486/486
(100 %)
3 diff
(99.4 %id)
T50780 Liver .vz 925 to 1345 1 to 423   tiling clone, Submitted on the opposite strand 423/429
(98 %)
6 diff
(98.7 %id)
N75914 multiple sclerosis lesions .wa-u 1 to 207 1 to 207   tiling clone,   207/207
(100 %)
1 diff
(99.6 %id)
N59177 multiple sclerosis lesions .wa-u 219 to 635 417 to 1   tiling clone,   417/417
(100 %)
2 diff
(99.6 %id)
BE856190 Prostate .wa-u 547 to 1122 599 to 24 exact tiling clone, AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base) 576/576
(100 %)
0 diff
(100 %id)
DA180484 amygdala .wb-u 1 to 558 2 to 560   tiling clone, capped   559/559
(100 %)
1 diff
(99.9 %id)
DA241835 brain .wb-u 330 to 913 2 to 585 exact tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
AW967998   .wc-u 1 to 676 1 to 675   tiling clone,   675/683
(98 %)
18 diff
(97.4 %id)
AA262292 germinal center B cell .wc-u 1 to 430 10 to 439   tiling clone,   430/439
(97 %)
6 diff
(98.7 %id)
AA281718 germinal center B cell .wc-u 166 to 523 1 to 357   fully sequenced,   357/357
(100 %)
14 diff
(96.1 %id)
AA286940 germinal center B cell .wc-u 437 to 907 469 to 1 N18I N19M E20K S21A L22* tiling clone,   469/469
(100 %)
5 diff
(99.0 %id)
AW271848 Kidney .wc-u 468 to 904 438 to 2 Q16P L31V tiling clone,   437/438
(99 %)
0 diff
(100 %id)
AA281719 germinal center B cell .wc-u 493 to 909 416 to 1 exact tiling clone, fully sequenced,   416/416
(100 %)
3 diff
(99.3 %id)
AA743292 germinal center B cell .wc-u 597 to 877 320 to 40   AAA   281/311
(90 %)
0 diff
(100 %id)
AA262177 germinal center B cell .wc-u 667 to 907 241 to 1       241/241
(100 %)
2 diff
(99.2 %id)
AL602015   .wd 1 to 605 605 to 1 exact tiling clone,   605/605
(100 %)
2 diff
(99.7 %id)
DA934340 Spleen .we-u 1 to 586 2 to 587 exact tiling clone, capped   586/586
(100 %)
0 diff
(100 %id)
AA921773 pooled .wf-u 1 to 545 546 to 0 exact tiling clone,   546/546
(100 %)
1 diff
(99.9 %id)
AW573184 pooled .wf-u 1 to 545 546 to 0 Q24R I25L V26Y     546/546
(100 %)
3 diff
(99.5 %id)
DB145823 thymus .wg-u 1 to 537 2 to 540 exact tiling clone, capped   539/539
(100 %)
2 diff
(99.7 %id)
BU429861 lymph .wh 1 to 387 7 to 393 exact tiling clone,   387/393
(98 %)
1 diff
(99.8 %id)
TI_154151030   .wh 1 to 527 79 to 605 exact tiling clone,   527/527
(100 %)
16 diff
(97.0 %id)
DA941610 Spleen .wi 1 to 495 6 to 500 exact tiling clone, capped   499/499
(100 %)
0 diff
(100 %id)
BI019815 marrow .wj-u 1 to 135 1 to 135       135/135
(100 %)
2 diff
(98.6 %id)
BI019945 marrow .wj-u 1 to 453 1 to 453 exact tiling clone,   453/453
(100 %)
0 diff
(100 %id)
BI021438 marrow .wj-u 1 to 380 1 to 380 S16*     380/380
(100 %)
1 diff
(99.8 %id)
BG429645 Kidney .wk-u 1 to 389 1 to 389 exact tiling clone,   389/391
(99 %)
2 diff
(99.5 %id)
CD706523 normal nasopharynx .wl-u 1 to 388 27 to 413 A12E G13E R14G N15T A17Q ... tiling clone,   394/413
(95 %)
6 diff
(98.6 %id)
DW428200 Liver .wm 1 to 259 18 to 276 exact tiling clone,   259/276
(93 %)
6 diff
(97.9 %id)
DW441701 Liver .wm 1 to 220 18 to 237       220/237
(92 %)
6 diff
(97.5 %id)
AK301317 stomach Gene SP140LandSP100andHMGB1L3, variant not shown         Suspected internal deletion, this clone was ignored    
AW939329 denis_drash Gene SP140LandSP100andHMGB1L3, variant not shown              
BF326998 breast_normal Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
BX644314   Gene SP140LandSP100andHMGB1L3, variant not shown              
FN124723 breast carcinoma Gene SP140LandSP100andHMGB1L3, variant not shown         Submitted on the opposite strand    
BP253981 Kidney Gene SP140LandSP100andHMGB1L3, variant not shown         Suspected internal deletion, this clone was ignored    
AA007525 liver and spleen Gene SP140LandSP100andHMGB1L3, variant not shown              
AA007526 liver and spleen Gene SP140LandSP100andHMGB1L3, variant not shown              
AA836847 Kidney, kidney tumor Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
BF516261   Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
BE896802 melanotic melanoma, skin Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
BQ053783 blood, natural killer cells, cell line Gene SP140LandSP100andHMGB1L3, variant not shown         Suspected internal deletion, this clone was ignored    
L79986 placenta Gene SP140LandSP100andHMGB1L3, variant not shown              
DB332004 small intestine Gene SP140LandSP100andHMGB1L3, variant not shown              
BP342835 stomach mucosa Gene SP140LandSP100andHMGB1L3, variant not shown         Suspected internal deletion, this clone was ignored    
DB141248 thymus Gene SP140LandSP100andHMGB1L3, variant not shown       capped      
DB345377 thymus Gene SP140LandSP100andHMGB1L3, variant not shown              
DB153661 thymus Gene SP140LandSP100andHMGB1L3, variant not shown       capped This clone was ignored    
DB346315 thymus Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
TI_154109729   Gene SP140LandSP100andHMGB1L3, variant not shown       AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base)    
DB183873 liver, tumor tissue Gene SP140LandSP100andHMGB1L3, variant not shown       capped This clone was ignored    
DB347635 liver, tumor tissue Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
DB213622 trachea Gene SP140LandSP100andHMGB1L3, variant not shown       capped This clone was ignored    
DB348905 trachea Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
U36499   Gene SP140LandSP100andHMGB1L3, variant not shown       AAA This clone was ignored    
CB851577 lung, Primary Lung Cystic Fibrosis EpithelialCells Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
CB853048 Human Lung Epithelial cells, lung Gene SP140LandSP100andHMGB1L3, variant not shown         This clone was ignored    
BM677472 eye, fetal eye Gene SP140LandSP100andHMGB1L3, variant not shown       fully sequenced, This clone was ignored    
BM723015 eye, fetal eye Gene SP140LandSP100andHMGB1L3, variant not shown       fully sequenced, This clone was ignored    
CA447975 Chondrosarcoma, Left Pelvis Gene SP140LandSP100andHMGB1L3, variant not shown       AAA Possibly primed on the genome, locally A rich (23/23 A in genome downstream of last aligned base)    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb-u, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk, .vl, .vm, .vn, .vo, .vp, .vq, .vr-u, .vs, .vt, .vu, .vv, .vw, .vx, .vy, .vz, .wa-u, .wb-u, .wc-u, .wd, .we-u, .wf-u, .wg-u, .wh, .wi, .wj-u, .wk-u, .wl-u, .wm, .wn-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI